Arcellx, Inc. — Investor Relations & Filings
Arcellx, Inc. is a clinical-stage biotechnology company that develops immunotherapies for patients with cancer and autoimmune diseases. The company is focused on reimagining cell therapy through its proprietary D-Domain technology. This technology is the foundation for its two main platforms: ddCAR, which produces autologous and allogeneic CAR-T therapies, and ARC-SparX, which involves controllable and adaptable cell therapies. Arcellx's lead investigational product, CART-ddBCMA, is in clinical development for the treatment of relapsed or refractory multiple myeloma. The company aims to create therapies that are safer, more effective, and more broadly accessible.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| S-8 POS - Arcellx, Inc. (0001786205) (Filer) | 2026-04-28 | English | |
| 25-NSE - Arcellx, Inc. (0001786205) (Subject) | 2026-04-28 | English | |
| 10-K/A - Arcellx, Inc. (0001786205) (Filer) | 2026-04-24 | English | |
| SCHEDULE 13G/A - Arcellx, Inc. (0001786205) (Subject) | 2026-03-26 | English | |
| 4 - Arcellx, Inc. (0001786205) (Issuer) | 2026-03-19 | English | |
| 4 - ARCELLX, INC. (0001786205) (Filer) | 2026-03-04 | English |
Browse filings by year
8 yearsMarket data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Cellectis
Develops allogeneic, or 'off-the-shelf', CAR T-cell immunot…
|
ALCLS | FR | Manufacturing |
|
Cellid Co., Ltd.
Develops immunotherapeutic vaccines for cancer and infectio…
|
299660 | KR | Manufacturing |
|
Cellromax Science Co., Ltd.
Researches and develops health foods, derma-cosmetics, and …
|
471820 | KR | Manufacturing |
|
CellSeed Inc.
Develops and commercializes cell sheet engineering for rege…
|
7776 | JP | Manufacturing |
|
Celltrion, Inc.
Biopharmaceutical firm developing biosimilars for autoimmun…
|
068270 | KR | Manufacturing |
|
Celltrion Pharm Inc.
Manufactures and supplies chemical pharmaceuticals and bios…
|
068760 | KR | Manufacturing |
|
CELLUMED CO., LTD.
Develops and manufactures medical devices, tissue grafts, a…
|
049180 | KR | Manufacturing |
|
Celon Pharma S.A.
An integrated pharmaceutical company researching and manufa…
|
CLN | PL | Manufacturing |
|
Celularity Inc
Develops allogeneic cell therapies and biomaterials from th…
|
CELU | US | Manufacturing |
|
Cenra Inc.
Diversified healthcare enterprise providing R&D, manufactur…
|
3716 | TW | Manufacturing |
Arcellx, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/31114/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=31114 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=31114 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=31114 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 31114}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Arcellx, Inc. (id: 31114)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.